Track the 씨유메디칼 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 씨유메디칼 has logged 2 public disclosures. Market capitalisation: €21.5bn. The latest transaction was disclosed on 17 March 2026 (Purchase). Among the most active insiders: 씨유코퍼레이션. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
씨유메디칼 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of medical products.